MINNEAPOLIS, July 31–(HSMN NewsFeed)–AGA Pharma Holdings, Inc. (AGA) today announced that a U.K. court has determined that an AGA-held patent for its Atrial Septal Defects (ASD) and Patent Foramen Ovale (PFO) devices is valid. However, the U.K. court de…
Devices, Cardiology, Litigation
AGA Pharma, Occlutech, Atrial Septal Defect, Patent Foramen Ovale
Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.
To get the details: Click Here
0 Comments on “AGA Pharmaceutical Patent Declared Valid in U.K. Patent Infringement Lawsuit against Occlutech”
Leave a Comment